Open Access

Advances in Heart Failure - Is it Time to Redefine Patient Selection for Sodium-glucose co-transporter 2 Inhibitors? - Organised by Radcliffe Medical Education, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an education

Topic: Pharmacotherapy
Organised by Radcliffe Medical Education, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Congress Presentation

Access the full session

Advances in Heart Failure - Is it Time to Redefine Patient Selection for Sodium-glucose co-transporter 2 Inhibitors?

Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb